At the same time, ZZCD could affect and participate in the process of neuroactive ligand/receptor interaction, regulate the HPA axis and secretion of prolactin and estrogen, and interfere with MAPK and TNF signaling pathways to reduce the level of inflammation to treat anxiety depression. Here, TNF is linked to mixed anxiety and depressive disorder.